InvestorsHub Logo
Followers 33
Posts 2049
Boards Moderated 0
Alias Born 11/06/2011

Re: plavac post# 34344

Tuesday, 11/28/2023 6:56:04 PM

Tuesday, November 28, 2023 6:56:04 PM

Post# of 34618
Absolutely agree that MRKR should take full advantage of this. They do need data to do so though and unfortunately that is not coming until the 1st half of next year. Hopefully more info comes from the FDA investigation early next year so MRKR can maybe get their data released around the same time. Either way, regardless of the FDA investigation ton CAR-Ts, I believe MRKR's lymphoma data will be sufficient enough to see a substantial increase in market valuation.

My DD is not a substitute for your DD

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News